Stocksigma LogoStocksigma Logo

Biocon Consortium Wins 10-Year Exclusive Pertuzumab Supply Contract in Brazil

Biocon Limited announced on 8th Sep'26 that its consortium with Bahiafarma and Bionovis secured a 100% allocation under Brazil's 10-year Productive

Biocon Consortium Wins 10-Year Exclusive Pertuzumab Supply Contract in Brazil

Biocon Ltd 路 Press Release 路 08 Sept 2026, 2:01 pm

Biocon Consortium Wins 10-Year Exclusive Pertuzumab Supply Contract in Brazil Biocon Limited announced on 8th Sep'26 that its consortium with Bahiafarma and Bionovis secured a 100% allocation under Brazil's 10-year Productive Development Partnership (PDP) program for Pertuzumab, a HER2-positive breast cancer therapy. The partnership grants exclusive access to Brazil鈥檚 public healthcare system, representing ~70% of the nation's demand for the drug. Biocon will receive milestone payments and revenue share over the 10-year period, with the product undergoing phased local manufacturing in Brazil over the mid-to-long term.

Original exchange filing (PDF)

More announcements from Biocon Ltd

All Biocon Ltd announcements